multiple-sclerosis

Documents about multiple-sclerosis

• Single cell landscape of sex differences in the different courses of multiple sclerosis#10121bioRxiv / medRxiv
• AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research.#125641NCBI PubMed Central
• Predicting multiple sclerosis from radiologically isolated syndrome using generative artificial intelligence#202235Europe PMC
• MPRAGE-derived quantitative T1 mapping to assess diffuse white matter alterations in multiple sclerosis.#266312bioRxiv / medRxiv
• Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study.#362092NCBI PubMed Central
• Brain age gap correlates with DTI-derived microstructural abnormalities in multiple sclerosis.#373567bioRxiv / medRxiv
• Manual federated simulation for multiple sclerosis integrating XGBoost algorithm with SHAP explanation.#421000NCBI PubMed Central
• Deep learning in imaging analysis for multiple sclerosis: Diagnosis and monitoring.#615790NCBI PubMed Central
• Effects of Gluteus Maximus Muscle Strength on Ataxia, Gait, and Equilibrium in Multiple Sclerosis#706433PhilArchive
• Representing disease courses: An application of the Neurological Disease Ontology to Multiple Sclerosis Typology#742708PhilArchive
• MS Spinal Mobilisation Study#804264ClinicalTrials.gov
• Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses#830739ClinicalTrials.gov
• The Effect of Anodal tDCS on Motor Learning in Multiple Sclerosis#835129ClinicalTrials.gov
• Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies#857643ClinicalTrials.gov
• Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)#871797ClinicalTrials.gov
• Sensor-based Technology for Upper Limb Rehabilitation#881150ClinicalTrials.gov
• Motor Skill Acquisition Between Individuals With Neurological Disorders and Healthy Individuals#885250ClinicalTrials.gov
• Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy#891131ClinicalTrials.gov
• Ocrevus Zunovo for MS: Mixed Methods#898098ClinicalTrials.gov
• PK and PD Study of Natalizumab in Pediatric Subjects With RRMS#967934ClinicalTrials.gov
• The Italian Multiple Sclerosis and Related Disorders Register#838222ClinicalTrials.gov
• A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo#826493ClinicalTrials.gov
• Comparing Stopping or Continuing Use of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis—The DISCOMS Trial#1997NCBI Bookshelf
• Cardiovascular comorbidities are associated with cross-sectional and longitudinal measures of multiple sclerosis fatigue.#125319NCBI PubMed Central
• Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis#202759IRIS
• Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidence.#236106NCBI PubMed Central
• Reproductive, Dietary, and Physical Activity Factors Associated With Multiple Sclerosis: A Case-Control Study.#338650NCBI PubMed Central
• Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple Sclerosis.#360563NCBI PubMed Central
• Psychosis in multiple sclerosis-a narrative review of an underestimated, but clinically significant problem.#425070NCBI PubMed Central
• Eyes closed single-leg stance test detects subtle sensorimotor decline in early multiple sclerosis.#440674NCBI PubMed Central
• Temporal changes in metabolism guide oligodendrocyte precursor cell dynamics in aging and multiple sclerosis.#469200NCBI PubMed Central
• Body Awareness, Trunk Stability, and Arm Function in MS#801839ClinicalTrials.gov
• Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis#829429ClinicalTrials.gov
• Kappa Index Versus Csf Oligoclonal Bands in Diagnosis of ms and Prediction of Disease Activity#857636ClinicalTrials.gov
• Gait Adaptability in Persons With MS Having Mild Disability#890628ClinicalTrials.gov
• Exercise in Severely Disabled Patients With MS#892912ClinicalTrials.gov
• Mechanistic Studies of Teriflunomide in RRMS#894675ClinicalTrials.gov
• Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).#895870ClinicalTrials.gov
• Intensive Multimodal Training for Persons With MS#966120ClinicalTrials.gov
• Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains#288188HAL (France)
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders#217105ClinicalTrials.gov
• Comparing the Effectiveness of Three Treatments for Reducing Fatigue among Patients with Multiple Sclerosis—The COMBO-MS Trial#1572NCBI Bookshelf
• Adjunctive strategies in multiple sclerosis treatment: non-pharmacological approaches and their potential clinical implications.#214191NCBI PubMed Central
• The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis.#242242NCBI PubMed Central
• Glycopeptides of hMOG(30-50) Detect Antibody Response in Multiple Sclerosis and other Neurological Diseases.#247024IRIS
• A multi-sequence MRI integration framework using SwinUNETR-v2 for multiple sclerosis lesion segmentation.#255266NCBI PubMed Central
• Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patients#266546Europe PMC
• Proximal Muscle Resistance Training to Improve Walking in People With Multiple Sclerosis: A Pilot Study.#327190NCBI PubMed Central
• Exploring attitudes and acceptance of artificial intelligence in multiple sclerosis from the patient perspective.#334969NCBI PubMed Central
• Predicting Depression and Anxiety Progression in Multiple Sclerosis from Longitudinal Clinical Data Using Machine Learning#398164bioRxiv / medRxiv